When the bacteria begin forming hard protective spores, a bulbous swelling develops near one end of the rod. This gives the cell a distinct drumstick or spindle-like silhouette.
Scientific Frontline / stock image
Scientific Frontline: Extended "At a Glance" Summary: Clostridioides difficile Transmission Modeling
The Core Concept: A stochastic network model designed to trace and quantify the transmission routes of Clostridioides difficile (C. diff) among immunocompromised patients in hospital oncology units.
Key Distinction/Mechanism: While traditional clinical protocols focus on testing and isolating symptomatic patients, this computational model captures invisible transmission events, revealing that asymptomatic colonized patients—those carrying the pathogen without clinical signs—are responsible for 92% of transmissions resulting in new colonizations.
Major Frameworks/Components:
- Stochastic Network Modeling: Simulates potential transmission routes by mathematically mapping every patient, room, and healthcare worker connection in a given ward.
- Active Patient Surveillance: Utilizes admission and weekly nucleic acid amplification testing (NAAT) alongside toxin enzyme immunoassays to calibrate the simulation and track hidden pathogen reservoirs.
- Asymptomatic Carrier Tracking: Quantifies the epidemiological impact of patients who import the pathogen into the ward without exhibiting illness, showing that testing alone only captures 23% of patients carrying the bacteria.
Branch of Science: Epidemiology, Infectious Disease Biology, Oncology, and Computational Modeling.
Future Application: This modeling framework can be adapted for other antimicrobial-resistant pathogens to help clinicians and hospital administrators identify critical contact points and design more effective, proactive infection control protocols.
Why It Matters: Advanced cancer treatments often leave patients severely immunocompromised, making secondary hospital-acquired infections like C. diff potentially fatal; recognizing asymptomatic carriers as the primary source of transmission is essential for protecting highly vulnerable populations and improving survival rates.
In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in hospital cancer units. They found that most new infections were introduced by patients who were infected but not symptomatic at the time of admission, rather than by patients who were infected and symptomatic. The model provides a clearer picture of C. diff transmission events in oncology wards and could help inform protocols aimed at preventing future disease transmission in a highly susceptible population.
Cancer treatments, while increasingly effective, leave their recipients immunocompromised and at greater risk of contracting infection than the general population. Hospital-acquired infections can cause severe complications in cancer patients, and C. diff is one of the most common.
“Physicians have singled out antimicrobial resistance as a big issue for improvement in cancer patients,” says Cristina Lanzas, professor of infectious disease at North Carolina State University’s College of Veterinary Medicine and corresponding author of the research.
“The cancer treatments are improved, but the secondary infections patients get because they are so immunocompromised can be fatal. We decided to look at how C. diff infections were transmitted in oncology wards.”
Generally speaking, clinicians test patients for C. diff only when they have clinical signs; however, patients can also carry this pathogen in the gut without symptoms and may contribute to its transmission.
The researchers combined six months of active patient surveillance (testing patients for C. diff regardless of clinical signs) with a simulation model of every room, patient, and staff connection on two cancer units. The data were provided by collaborators at Washington University School of Medicine.
“Testing data only provide a snapshot—are you positive or negative on a given day and time—but transmission events are invisible,” Lanzas says. “We developed models that traced potential transmission routes and then looked at each model’s ability to replicate actual infection data. Then we chose the model that aligned best with the data we had.”
According to the model, testing alone captures only 23% of patients carrying C. diff.
The modeling also revealed that patients with active C. diff infections were not the main source of new colonization. Rather, asymptomatic colonized (AC) patients—people who carry C. diff but don’t have clinical signs—were responsible for 92% of transmissions that resulted in new colonizations.
The researchers hope that their model could be applied to different pathogens to help clinicians and hospitals identify contact points where risks for infections are increased.
“The issue of people carrying pathogens without knowing about it is very common with all antimicrobial-resistant pathogens—we can really be our own worst enemies,” Lanzas says. “But by modeling these events, we can make the invisible visible, and perhaps that can lead to new protocols for patients coming into these wards.”
Funding: Centers for Disease Control and Prevention (grants BAA #200-2018-02926 and U01CK000587) and the National Science Foundation Graduate Research Fellowship Program (grant DGE-2137100), and received approximately 50% of its funding from the National Institutes of Health.
Published in journal: Infection Control and Hospital Epidemiology,
Authors: Savannah Curtis, Mary M. Lee, Tiffany Hink, Kimberly A. Reske, Emily Struttmann, Zainab Hassan Iqbal, Candice Cass, Margaret Olsen, Sankalp Arya, Carey-Ann Burnham, Suzanne Lenhart, Erik Dubberke, and Cristina Lanzas
Source/Credit: North Carolina State University | Tracey Peake
Edited by: Scientific Frontline
Reference Number: epi100526_01
.jpg)
